Osaic Holdings’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.58M | Sell |
69,426
-10,633
| -13% | -$395K | 0.01% | 1471 |
|
|
2025
Q1 | $1.93M | Buy |
80,059
+24,775
| +45% | +$598K | ﹤0.01% | 1704 |
|
|
2024
Q4 | $2.22M | Buy |
55,284
+19,091
| +53% | +$768K | 0.01% | 1572 |
|
|
2024
Q3 | $2.29M | Buy |
36,193
+8,002
| +28% | +$507K | 0.01% | 1592 |
|
|
2024
Q2 | $1.49M | Sell |
28,191
-2,735
| -9% | -$145K | ﹤0.01% | 1848 |
|
|
2024
Q1 | $2.54M | Buy |
30,926
+1,040
| +3% | +$85.3K | 0.01% | 1520 |
|
|
2023
Q4 | $556K | Sell |
29,886
-193,409
| -87% | -$3.6M | ﹤0.01% | 3071 |
|
|
2023
Q3 | $2.47M | Buy |
223,295
+114,863
| +106% | +$1.27M | ﹤0.01% | 1802 |
|
|
2023
Q2 | $1.76M | Sell |
108,432
-18,939
| -15% | -$307K | ﹤0.01% | 1989 |
|
|
2023
Q1 | $2.12M | Sell |
127,371
-20,533
| -14% | -$342K | ﹤0.01% | 1785 |
|
|
2022
Q4 | $1.39M | Buy |
147,904
+1,466
| +1% | +$13.8K | ﹤0.01% | 2052 |
|
|
2022
Q3 | $399K | Buy |
146,438
+5,187
| +4% | +$14.1K | ﹤0.01% | 3109 |
|
|
2022
Q2 | $408K | Buy |
141,251
+31,887
| +29% | +$92.1K | ﹤0.01% | 3135 |
|
|
2022
Q1 | $929K | Buy |
109,364
+20,228
| +23% | +$172K | ﹤0.01% | 2645 |
|
|
2021
Q4 | $410K | Buy |
89,136
+9,171
| +11% | +$42.2K | ﹤0.01% | 3255 |
|
|
2021
Q3 | $502K | Buy |
79,965
+2,200
| +3% | +$13.8K | ﹤0.01% | 3025 |
|
|
2021
Q2 | $466K | Buy |
77,765
+5,320
| +7% | +$31.9K | ﹤0.01% | 3106 |
|
|
2021
Q1 | $458K | Sell |
72,445
-2,770
| -4% | -$17.5K | ﹤0.01% | 2956 |
|
|
2020
Q4 | $423K | Buy |
75,215
+2,930
| +4% | +$16.5K | ﹤0.01% | 2809 |
|
|
2020
Q3 | $422K | Buy |
72,285
+11,387
| +19% | +$66.5K | ﹤0.01% | 2584 |
|
|
2020
Q2 | $439K | Buy |
60,898
+17,077
| +39% | +$123K | ﹤0.01% | 2460 |
|
|
2020
Q1 | $204K | Buy |
+43,821
| New | +$204K | ﹤0.01% | 2849 |
|